When a high-concentration probiotic (De Simone Formulation) was first included in the Gastroenterology Guidelines for the dietary management for IBD (Inflammatory Bowel Diseases) patients, it caused quite a stir. Analyzing this strategy in depth has allowed researchers to identify essential differences between the components included in the wide range of food supplements.A [...]
At the University of Perugia, the team coordinated by Stefano Fiorucci further deepened the concept of dysbiosis with the aim to find out strategies that can improve the prognosis in patients with chronic inflammatory bowel diseases (IBD). The research team from the Department of Biomedical and Surgical Sciences analyzed the relationship [...]
Inflammatory Bowel Diseases (IBD) affect 200,000 people in France and these pathologies still can’t be cured despite therapeutic advances in the treatment of symptoms for Crohn's disease and ulcerative colitis. Years of research have identified factors related to these diseases. It is known that IBD is linked to immune dysfunction, that [...]
Patients do not always respond equally to a specific treatment, but when research can predict the efficacy or ineffectiveness of a treatment on a case-by-case basis, this implies a real improvement in the therapeutic care. As far as Inflammatory Bowel Diseases (IBD) are concerned for example, 40% of patients, ie. 2 [...]
World IBD Day is committed to raising awareness and improve life for people with IBD. Around the world, patients associations representing 38 countries are mobilized to make this day a global event. Source: the European Federation of Crohn´s and Ulcerative Colitis Associations organisation (EFCCA) According to EFCCA from which we [...]
The IBD meeting not to be missed The IBD, one of the major international meetings of Inflammatory Bowel Diseases (IBD), is taking place this year in Barcelona from 15 to 18 February. Researchers, clinicians, practitioners will share and comment on the results of the latest clinical studies and therapeutic advances in this field. [...]
Confirmed interest for the 8 strains / 450 billion probiotic blend in ulcerative colitis and its infectious complications The updated recommendations at the 4th Triennial Yale/Harvard Workshop on Probiotic Use held in New Haven (USA) in March 2015 confirm the effectiveness of this probiotic blend. « … this blend of [...]
watch the video Dr Harry Sokol, The microbiota: a major actor 9th National IBD Conference, Paris 22 Jan. 2016 – Fecal transplantation targeting the intestinal microbiota is in the early stages in IBD. An interview with Dr. Harry Sokol of the St Antoine Hospital in Paris AFA WEB TV ®2016 Fecal [...]
Overcoming IBD: The AFA is committed to advancing research I greet Alain Olympie and the committed and solidary members of the AFA Association François Aupetit, for the operation “Let's show what we have in the belly” in order to raise € 100,000 funds. Created in 1982 and recognized as a public utility, AFA [...]